Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [906]
News [2550]
Articles [106]
Editorials [3]
Conferences [84]
elearning [20]
Weekly Review of oncology literature compiled by Giuseppe Curigliano, Division of Medical Oncology, Istituto Europeo di Oncologia, Milan, Italy
Weekly Review of oncology literature compiled by Giuseppe Curigliano, Division of Medical Oncology, Istituto...
Arsenic exposure activates oncogenic signaling pathway
Arsenic exposure activates oncogenic signaling pathway
Economic analysis: Erlotinib marginally cost-effective
Economic analysis: Erlotinib marginally cost-effective
Denosumab breakthrough for rare bone tumour
Denosumab breakthrough for rare bone tumour
Drug with unique disruption of tumour blood flow shows promise
Drug with unique disruption of tumour blood flow shows promise
The difficulties of patient access schemes for high-cost cancer medicines
The difficulties of patient access schemes for high-cost cancer medicines
Second round of gefitinib may be promising lung cancer therapy
Second round of gefitinib may be promising lung cancer therapy
Drug with unique disruption of tumour blood flow shows promise
Drug with unique disruption of tumour blood flow shows promise
Gene testing identifies lung cancer patients who benefit from ALK-inhibitor drug
Gene testing identifies lung cancer patients who benefit from ALK-inhibitor drug
MicroRNA profiling identifies chemoresistance in Small Cell Lung Cancer
MicroRNA profiling identifies chemoresistance in Small Cell Lung Cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation